Cancer Research Cancer Health Disparities Conference 2009  AM No Date
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dadke, D.
Right arrow Articles by Field, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dadke, D.
Right arrow Articles by Field, J.
[Cancer Research 63, 8837-8847, December 15, 2003]
© 2003 American Association for Cancer Research


Regular Articles

Activation of p21-Activated Kinase 1-Nuclear Factor {kappa}B Signaling by Kaposi’s Sarcoma-Associated Herpes Virus G Protein-Coupled Receptor during Cellular Transformation

Disha Dadke12, Benjamin H. Fryer1, Erica A. Golemis2 and Jeffrey Field1

1 Department of Pharmacology, University of Pennsylvania, School of Medicine, Philadelphia, Pennsylvania, and
2 Division of Basic Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania

Kaposi’s sarcoma-associated herpes virus (KSHV) contributes to the pathogenesis of Kaposi’s sarcoma and primary effusion lymphomas. KSHV encodes a G protein-coupled receptor (KSHV-GPCR) that signals constitutively and transforms NIH3T3 cells. Here, we show that KSHV-GPCR transformation requires activation of the small G protein Rac1 and its effector, the p21-activated kinase 1 (Pak1). Either transient or sustained expression of KSHV-GPCR activated both Rac1 and Pak1. Furthermore, expression of dominant-negative mutants of Rac (RacN17) or Pak1 (PakR299, Pak-PID) inhibited KSHV-GPCR-induced focus formation and growth in soft agar. We also demonstrate that signaling from Pak1 to nuclear factor-{kappa}B (NF{kappa}B) is required for cell transformation induced by KSHV-GPCR. KSHV-GPCR induced transcriptional activation by NF{kappa}B. This process is inhibited by the PAK-PID, whereas reciprocally, expression of constitutively active Pak1 (PakL107F) activated NF{kappa}B comparably to KSHV-GPCR. The Pak-PID and RacN17 inhibited the KSHV-GPCR-induced phosphorylation of inhibitor of {kappa}B kinase-ß and inhibitor of {kappa}B-{alpha}, implying that it is Pak1-dependent phosphorylation and subsequent destruction of the inhibitor of {kappa}B proteins that allows NF{kappa}B activation. Finally, experiments with the KSHV-GPCR inverse agonist interferon-{gamma}-inducible protein-10, the G{alpha}i inhibitor pertussis toxin, and an inhibitor of phosphatidylinositol 3'-kinase, wortmannin, indicate that signaling through the G{alpha}i pathway and phosphatidylinositol 3'-kinase contributes to the cell transformation and NF{kappa}B activation induced by the KSHV-GPCR.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. J. Martin, T. Tanos, A. B. Garcia, D. Martin, J. S. Gutkind, O. A. Coso, and M. J. Marinissen
The G{alpha}12/13 Family of Heterotrimeric G Proteins and the Small GTPase RhoA Link the Kaposi Sarcoma-associated Herpes Virus G Protein-coupled Receptor to Heme Oxygenase-1 Expression and Tumorigenesis
J. Biol. Chem., November 23, 2007; 282(47): 34510 - 34524.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
J. C. Friedland, J. N. Lakins, M. G. Kazanietz, J. Chernoff, D. Boettiger, and V. M. Weaver
{alpha}6beta4 integrin activates Rac-dependent p21-activated kinase 1 to drive NF-{kappa}B-dependent resistance to apoptosis in 3D mammary acini
J. Cell Sci., October 15, 2007; 120(20): 3700 - 3712.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Caselli, S. Fiorentini, C. Amici, D. Di Luca, A. Caruso, and M. G. Santoro
Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF-{kappa}B pathway
Blood, April 1, 2007; 109(7): 2718 - 2726.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
N. Skobeleva, S. Menon, L. Weber, E. A. Golemis, and V. Khazak
In vitro and in vivo synergy of MCP compounds with mitogen-activated protein kinase pathway- and microtubule-targeting inhibitors
Mol. Cancer Ther., March 1, 2007; 6(3): 898 - 906.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. J. Paulsen, M. M. Rosenkilde, J. Eugen-Olsen, and T. N. Kledal
Epstein-Barr Virus-Encoded BILF1 Is a Constitutively Active G Protein-Coupled Receptor
J. Virol., January 1, 2005; 79(1): 536 - 546.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.